Digital tools for remote monitoring, needs assessment, self-management advice and supportive care strategies

This pilot supports the integration of polygenic risk scores in screening programes, particularly for breast and prostate cancer. It harmonises workflows, governance, patient communication, and reimbursement pathways across Member States to ensure readiness and equity in future implementation.

The Joint Action on Personalised Cancer Medicine (JA PCM) is structured into 9 Pilots. JA PCM brings together expertise from 146 organisations across 29 countries to carry out coordinated activities under three thematic "Arms" (Prevention, Medicine, and Follow-up) and several cross-cutting areas. Each WP is led or co-led by national authorities or expert institutions and contributes to achieving the JA’s overarching goals.

h3 title